4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine

C25H29ClFN7 — CID 87589309

IUPAC4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine
SMILESCc1cc(-c2cc(N3CCN(c4nccnc4Cl)CC3C)nc(N3CCCC3C)n2)ccc1F
InChIInChI=1S/C25H29ClFN7/c1-16-13-19(6-7-20(16)27)21-14-22(31-25(30-21)34-10-4-5-17(34)2)33-12-11-32(15-18(33)3)24-23(26)28-8-9-29-24/h6-9,13-14,17-18H,4-5,10-12,15H2,1-3H3
InChIKeyVYGBXUBRFVSXBS-UHFFFAOYSA-N
MW482.01 g/mol
LogP4.74
Rot. Bonds4

About 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine

4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine (PubChem CID 87589309) has the molecular formula C25H29ClFN7 and a molecular weight of 482.01 g/mol. Its IUPAC name is 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine.

Molecular Properties

Compound Name4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine
PubChem CID87589309
Molecular FormulaC25H29ClFN7
Molecular Weight482.01 g/mol
Exact Mass481.22
IUPAC Name4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine
SMILESCc1cc(-c2cc(N3CCN(c4nccnc4Cl)CC3C)nc(N3CCCC3C)n2)ccc1F
InChIInChI=1S/C25H29ClFN7/c1-16-13-19(6-7-20(16)27)21-14-22(31-25(30-21)34-10-4-5-17(34)2)33-12-11-32(15-18(33)3)24-23(26)28-8-9-29-24/h6-9,13-14,17-18H,4-5,10-12,15H2,1-3H3
InChIKeyVYGBXUBRFVSXBS-UHFFFAOYSA-N
XLogP4.74
TPSA61.28 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500482.01
LogP ≤ 54.74
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine?
The IUPAC name of 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine (CID 87589309) is 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine.
What is the SMILES notation for 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine?
The canonical SMILES for 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine is Cc1cc(-c2cc(N3CCN(c4nccnc4Cl)CC3C)nc(N3CCCC3C)n2)ccc1F.
What is the InChIKey of 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine?
The InChIKey is VYGBXUBRFVSXBS-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H29ClFN7/c1-16-13-19(6-7-20(16)27)21-14-22(31-25(30-21)34-10-4-5-17(34)2)33-12-11-32(15-18(33)3)24-23(26)28-8-9-29-24/h6-9,13-14,17-18H,4-5,10-12,15H2,1-3H3.
What are the key properties of 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine?
4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine has a molecular weight of 482.01 g/mol, XLogP of 4.74, 4 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-(3-chloropyrazin-2-yl)-2-methylpiperazin-1-yl]-6-(4-fluoro-3-methylphenyl)-2-(2-methylpyrrolidin-1-yl)pyrimidine is sourced from PubChem (CID 87589309), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).